Skip to main content

Crescent Biopharma, Inc 10-K for FY2021

Crescent Biopharma, Inc. (CBIO)

10-K 2022-03-03 For: 2021-12-31
View Original
Added on April 10, 2026

About this 10-K

Crescent Biopharma, Inc filed this 10-K on March 3, 2022, covering the fiscal year ended December 31, 2021 (FY2021).

Headline figures

Fiscal year ended December 31, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$1.16M
down 88.6% from $10.16M a year earlier
Net loss
$63.43M
compared with a net loss of $51.03M a year earlier
Diluted EPS
-$1.23
compared with -$1.12 a year earlier